Skip to main content

Table 2 Fatty acid composition of cardiac phospholipids

From: Dietary canolol protects the heart against the deleterious effects induced by the association of rapeseed oil, vitamin E and coenzyme Q10 in the context of a high-fat diet

 

C

PS

R

RTC

RTCC

12:0

0.03 ± 0.01

0.04 ± 0.01

0.03 ± 0.01

0.03 ± 0.01

0.03 ± 0.01

14:0

0.17 ± 0.01a

0.15 ± 0.01ac

0.13 ± 0.01cd

0.12 ± 0.01bde

0.13 ± 0.01ce

15:0

0.09 ± 0.01a

0.03 ± 0.01b

0.04 ± 0.01b

0.04 ± 0.01b

0.04 ± 0.01b

DMA 16:0

2.33 ± 0.06a

3.14 ± 0.05b

2.74 ± 0.14c

2.88 ± 0.06c

2.85 ± 0.06c

16:0

11.90 ± 0.33

11.98 ± 0.29

12.11 ± 0.34

11.85 ± 0.16

12.35 ± 0.28

17:0

0.32 ± 0.01a

0.12 ± 0.01b

0.14 ± 0.01b

0.13 ± 0.01b

0.14 ± 0.01b

DMA 18:0

0.81 ± 0.09a

1.02 ± 0.06b

0.91 ± 0.03ab

1.00 ± 0.09ab

0.93 ± 0.05ab

18:0

19.53 ± 0.31a

22.25 ± 0.29b

21.27 ± 0.48c

21.17 ± 0.09c

20.88 ± 0.07c

20:0

0.18 ± 0.02ac

0.17 ± 0.02a

0.23 ± 0.01bd

0.25 ± 0.01bd

0.22 ± 0.01cd

22:0

0.16 ± 0.01a

0.31 ± 0.01b

0.21 ± 0.01c

0.22 ± 0.02c

0.20 ± 0.01c

24:0

0.01 ± 0.01a

0.08 ± 0.01b

0.02 ± 0.01a

0.02 ± 0.01a

0.02 ± 0.01a

SFA

35.21 ± 0.33a

39.29 ± 0.24b

37.86 ± 0.50c

37.56 ± 0.21c

37.56 ± 0.16c

16:1ω9

0.10 ± 0.01a

0.08 ± 0.01b

0.10 ± 0.01a

0.08 ± 0.01bc

0.09 ± 0.01ac

16:1ω7

0.47 ± 0.05a

0.1 ± 0.01b

0.08 ± 0.02b

0.08 ± 0.01b

0.11 ± 0.02b

18:1ω9

3.89 ± 0.22a

6.79 ± 0.45b

7.21 ± 0.60b

6.09 ± 0.20b

6.60 ± 0.40b

18:1ω7

4.09 ± 0.10a

2.50 ± 0.02b

2.88 ± 0.04c

2.93 ± 0.05c

3.00 ± 0.04c

20:1ω9

0.11 ± 0.01a

0.06 ± 0.01b

0.06 ± 0.01b

0.05 ± 0.01b

0.05 ± 0.01b

MUFA

8.66 ± 0.34a

9.50 ± 0.47ab

10.32 ± 0.62b

9.21 ± 0.16ab

9.78 ± 0.47ab

18:2ω6

24.22 ± 0.87a

12.24 ± 0.46b

14.28 ± 0.57c

15.48 ± 0.56c

14.72 ± 0.31c

18:3ω6

0.06 ± 0.01a

0.07 ± 0.01a

0.14 ± 0.01c

0.11 ± 0.01b

0.12 ± 0.01bc

20:2ω6

0.19 ± 0.01a

0.10 ± 0.01b

0.11 ± 0.01b

0.11 ± 0.01b

0.12 ± 0.01b

20:3ω6

0.31 ± 0.01a

0.38 ± 0.01b

0.43 ± 0.03c

0.50 ± 0.02d

0.46 ± 0.02cd

20:4ω6

21.70 ± 0.34a

26.13 ± 0.50b

21.76 ± 0.76a

21.52 ± 0.45a

20.68 ± 0.39a

22:4ω6

1.21 ± 0.05a

1.44 ± 0.04b

0.61 ± 0.01c

0.58 ± 0.02c

0.56 ± 0.02c

22:5ω6

1.38 ± 0.09a

6.58 ± 0.58b

0.48 ± 0.05c

0.46 ± 0.02c

0.50 ± 0.03c

ω6 PUFA

48.73 ± 0.52a

46.93 ± 0.53b

37.82 ± 0.41c

38.77 ± 0.50c

37.74 ± 0.35c

18:3ω3

0.15 ± 0.01a

0.02 ± 0.01b

0.22 ± 0.02c

0.19 ± 0.01c

0.20 ± 0.01c

20:5ω3

0.12 ± 0.01a

0.09 ± 0.01b

0.10 ± 0.01ab

0.11 ± 0.01ab

0.10 ± 0.01ab

22:5ω3

1.22 ± 0.07a

0.57 ± 0.02b

2.42 ± 0.12c

2.71 ± 0.16cd

2.88 ± 0.18d

22:6ω3

5.59 ± 0.27a

3.61 ± 0.15b

11.26 ± 0.39c

11.47 ± 0.38c

11.28 ± 0.36c

ω3 PUFA

7.09 ± 0.32a

4.28 ± 0.16b

14.0 ± 0.40c

14.48 ± 0.36c

14.45 ± 0.51c

PUFA

55.53 ± 0.28a

51.21 ± 0.52cd

51.82 ± 0.59bd

52.98 ± 0.21b

52.37 ± 0.54bc

ω6/ω3

6.99 ± 0.38a

11.09 ± 0.47b

2.72 ± 0.08c

2.69 ± 0.10c

2.60 ± 0.10c

EPA + DHA

5.71 ± 0.27a

3.70 ± 0.16b

11.36 ± 0.39c

11.58 ± 0.37c

11.37 ± 0.36c

EPA/AA (×  103)

5.08 ± 0.44a

3.36 ± 0.44b

4.61 ± 0.31a

5.07 ± 0.43a

4.62 ± 0.29a

(EPA + DHA)/AA

0.27 ± 0.01a

0.14 ± 0.01b

0.53 ± 0.02c

0.54 ± 0.02c

0.55 ± 0.02c

PUFA/SFA

1.563 ± 0.005a

1.304 ± 0.018b

1.371 ± 0.028c

1.406 ± 0.012c

1.395 ± 0.019c

  1. C control rats, PS rats fed a palm oil/sunflower oil mixture, R rats fed rapeseed oil, RTC rats fed rapeseed oil enriched with α-tocopherol and coenzyme Q10, RTCC rats fed RTC plus canolol, DMA dimethylacetal, SFA saturated fatty acid, MUFA monounsaturated fatty acid, PUFA polyunsaturated fatty acid, EPA eicosapentaenoic acid or C20:5ω3, DHA docosahexaenoic acid or C22:6ω3, AA arachidonic acid or C20:4ω6. Averages of 5 rats per group
  2. a, b, c, d, emeans in a row without a common letter are significantly different